You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Johnson and Johnson
Express Scripts
Mallinckrodt

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

Litigation Details for IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-12-20 1 and legally issued United States Patent No. 9,089,608 (“the ’608 patent”) entitled “Controlled Release …prior to the expiration of United States Patent No. 9,089,608. … U.S. Patent No. 9,089,608 On June 28, 2015, the PTO…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…term of the ’608 patent would further infringe at least claim 21 of the ’608 patent under 35 U.S.C. External link to document
2018-11-28 103 of equivalents, any valid claim of U.S. Patent Nos. 7,094,427; 8,377,474; 8,454,998; 8,557,283; and 9,… 2017 19 May 2020 2:17-cv-13476 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-07-25 145 component” in various claims in U.S. Patent No. 8,377,474 (the “’474 patent”) and found that, during prosecution…collectively, “Zydus”). In this patent infringement suit involving a pharmaceutical patent, the parties seek construction…construction of a claim term in U.S. Patent No. 9,089,608 (“the ’608 patent”). The parties dispute … attaches to the patent and then spreads to every limb and leaf in the family patent tree. It is not …prosecution of the ‘474 patent, cannot, 1 Zydus claims that the claims in the ‘474 patent also contained External link to document
2020-03-23 211 Order on Motion in Limine from a patent infringement dispute involving a pharmaceutical patent, U.S. Patent No. 9,089,608 (“the …the ’608 patent”). Claim 21 of this patent is at issue. The preamble of claim 21 states: “A controlled… 1 contention that the patent is void for indefiniteness. The parties… 2017 19 May 2020 2:17-cv-13476 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Johnson and Johnson
Colorcon
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.